These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8432811)

  • 1. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
    Roberts BD; Foung SK; Lipka JJ; Kaplan JE; Hadlock KG; Reyes GR; Chan L; Heneine W; Khabbaz RF
    J Clin Microbiol; 1993 Feb; 31(2):260-4. PubMed ID: 8432811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
    Kleinman SH; Kaplan JE; Khabbaz RF; Calabro MA; Thomson R; Busch M
    J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
    Lipka JJ; Santiago P; Chan L; Reyes GR; Samuel KP; Blattner WA; Shaw GM; Hanson CV; Sninsky JJ; Foung SK
    J Infect Dis; 1991 Aug; 164(2):400-3. PubMed ID: 1856487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
    Lal RB; Brodine S; Kazura J; Mbidde-Katonga E; Yanagihara R; Roberts C
    J Clin Microbiol; 1992 Feb; 30(2):296-9. PubMed ID: 1347047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of two enzyme-linked immunosorbent assay tests in relation to western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, Brazil.
    Caterino-de-Araujo A; de los Santos-Fortuna E; Meleiro MC; Suleiman J; Calabrò ML; Favero A; De Rossi A; Chieco-Bianchi L
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):173-82. PubMed ID: 9572023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
    Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
    J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH; McAlpine L; Mortimer PP
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA; Eirin ME; Pando MA; Biglione MM
    J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
    Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for diagnosis of HTLV-I and -II.
    Thorstensson R; Albert J; Andersson S
    Transfusion; 2002 Jun; 42(6):780-91. PubMed ID: 12147033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prototypical HTLV-I/II infection is rare in LGL leukemia.
    Loughran TP; Sherman MP; Ruscetti FW; Frey S; Coyle T; Montagna RA; Jones B; Starkebaum G; Poiesz BJ
    Leuk Res; 1994 Jun; 18(6):423-9. PubMed ID: 8207960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
    Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
    J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
    Abrams A; Akahata Y; Jacobson S
    Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors.
    Anderson DW; Epstein JS; Lee TH; Lairmore MD; Saxinger C; Kalyanaraman VS; Slamon D; Parks W; Poiesz BJ; Pierik LT
    Blood; 1989 Nov; 74(7):2585-91. PubMed ID: 2804381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil.
    Jacob F; Santos-Fortuna Ede L; Azevedo RS; Caterino-de-Araujo A
    Rev Inst Med Trop Sao Paulo; 2007; 49(6):361-4. PubMed ID: 18157402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.
    Malm K; Kjerstadius T; Andersson S
    J Med Virol; 2010 Sep; 82(9):1606-11. PubMed ID: 20648617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
    Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
    Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.